Related Experiment Video
Updated: Jul 6, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski1, Andrea Boni, Paul A Antony
1Center for Cancer Research, National Cancer Institute, National Institutes of Health, Mark O. Hatfield Clinical Research Center, Bethesda, MD 20892, USA. muranskp@mail.nih.gov
Blood
|March 21, 2008
Summary
This study reveals that Th17-polarized CD4+ T cells, not Th1 cells, are more effective in rejecting B16 melanoma. Their anti-tumor immunity relies on interferon-gamma (IFN-γ) production, offering insights for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Background:
- CD4+ T cells exhibit diverse effector functions crucial for anti-tumor immunity.
- The specific roles of different CD4+ T cell subsets in tumor rejection remain incompletely understood.
- Existing paradigms emphasize Th1 cells' importance in tumor rejection.
Purpose of the Study:
- To investigate the impact of CD4+ T cell polarization on tumor rejection.
- To evaluate the efficacy of different T helper cell subsets (Th1, Th17) in a murine melanoma model.
- To inform the design of adoptive T cell transfer immunotherapies for human cancers.
Main Methods:
- Generation of a novel MHC class II-restricted TCR transgenic mouse model recognizing tyrosinase-related protein 1 (TRP-1).
- In vitro polarization of CD4+ T cells into Th0, Th1, and Th17 subtypes.
- Assessment of effector function in vivo against established B16 murine melanoma.
Main Results:
- Th17-polarized CD4+ T cells demonstrated superior therapeutic efficacy against advanced B16 melanoma compared to Th1 cells.
- The anti-tumor effect of Th17 cells was dependent on interferon-gamma (IFN-γ) production.
- Depletion of interleukin-17A (IL-17A) and IL-23 did not significantly impair the therapeutic effect.
Conclusions:
- In vitro polarization of CD4+ T cells is critical for effective tumor eradication.
- Th17 cells, via IFN-γ, play a significant role in anti-tumor immunity, challenging the Th1-centric view.
- Findings have implications for optimizing adoptive T cell transfer strategies in cancer immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...